407 results on '"Somay, Efsun"'
Search Results
2. In Regard to Joseph et al. (2023) (https://doi.org/10.1007/s12070-023-04416-7)
3. The unique CARWL score stratifies locally advanced nasopharyngeal cancer patients receiving concurrent chemoradiotherapy into risk groups for radiation-induced trismus
4. In regard to Castagnola et al. (doi: 10.1186/s12903-023-03050-7)
5. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers
6. Comment on Konishi et al.
7. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas
8. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients
9. In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)
10. Valero’s host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients
11. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
12. Comment on: Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer
13. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients
14. Letter to the editor: preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer
15. Comment on: Intensity Modulated Radiotherapy in Head and Neck Cancer: Initial Experience of the First Treated Cases from North-East India
16. Letter to the Editor regarding “Long‑term swallow outcomes and factors affecting swallowing dysfunction and quality of life among oral cancer patients: a prospective observational study” by Thaduri et al. Eur Arch Otorhinolaryngol. 2023 Aug 7. doi: 10.1007/s00405-023–08155-x
17. Radiotherapy and Dental Implant Applications in Patients with Head and Neck Cancer
18. Oral Microbiota: As a Cause of Head and Neck Cancers
19. Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
20. In Regard to Nath et al. (2022) (doi: 10.1007/s12070-021-02941-x)
21. In Regard to Xu et al
22. Global immune-nutrition-inflammation index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients
23. In Reference to Treatment Outcome in Head and Neck Cancer with Distant Metastasis at Initial Diagnosis
24. Comment on Sasaki et al. (https://doi.org/10.1111/odi.14865)
25. Comment on Frydrych et al. (https://doi.org/10.1111/odi.14837)
26. Periodontitis can Negatively Impact the Survival Outcomes of Cancer Patients
27. The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
28. Definitions of Radiation-induced Trismus in Head and Neck Cancer: Current Concepts and Controversies
29. Challenges in the Radiological Diagnosis of Osteoradionecrosis of the Jaw in Head and Neck Cancer Patients
30. Assessment of the Impact of Osteoradionecrosis on Quality-of-Life Measures in Patients with Head and Neck Cancer
31. Radiation-induced Trismus and Related Measures of Patient Life Quality
32. Letter to the Editor: Comment on Chiu TH, et al. A Comparison Study of Outcomes and Complications Between Marginal Mandibulectomy With or Without Additional Mandibulotomy in Tongue Cancers (Ann Plast Surg. 2023;90(1 suppl 1):S37–S43)
33. Letter to the Editor: To extract or not extract teeth prior to head and neck radiotherapy?
34. Radiation- Induced Trismus: A Concise Review of Pathogenesis, Prevention and Management
35. Persistent Inflammation as a Cause of Severe Late Complications in Chemoradiotherapy-treated Head and Neck Cancer Patients
36. Novel Index Combining Pan‐Immune‐Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer.
37. Causes of Delays in Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients
38. Comment on Survivin -31G/C polymorphism and disease fate in of oral squamous cell carcinomas
39. In reply to Melachuri et al. (https://doi.org/10.1016/j.oraloncology.2024.106703)
40. Comment on Poor Dental Health as a Risk Factor for Alveolar Ridge Malignancies
41. Response to Deantoni et al.
42. Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
43. Potential contributors to implant losses following radiotherapy or chemoradiotherapy
44. Tooth Extraction and Osteoradionecrosis
45. Re: Minimum detectable change in occlusal load – Normative data for healthy and head and neck cancer populations
46. Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx
47. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients
48. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas
49. Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report
50. Letter to the Editor: Local Treatment of Children Suffering From Parameningeal Rhabdomyosarcoma - A Retrospective Single-Center Study From China
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.